- Investigator
- Luis G Ortega Paz
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
Treats Adults
Luis G Ortega Paz, MD
Cardiologist
- Additional languages:
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Research activity
Active clinical trials
- Investigator
- Luis G Ortega Paz
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
- Investigator
- Luis G Ortega Paz
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
My publications
Filter publications
59 publications
2023
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions
2023
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study
Thrombosis and Haemostasis
2023
Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation
Circulation
2022
Impact of Diabetes on 10Year Outcomes Following STSegmentElevation Myocardial Infarction: Insights From the EXAMINATIONEXTEND Trial
Journal of the American Heart Association
2022
Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot
European Heart Journal